The purported health benefits now appear to be even more far-reaching, with the latest data from a trial called Select, published in 2023, showing that semaglutide can slash the risk of heart attacks and strokes by a fifth in patients with an existing history of cardiovascular disease
A score of three or more should prompt referral, especially when features such as inflammation, oozing or bleeding, and change in sensation are present
You should also contact your provider if: At-home remedies provide no relief at all
Why Do GLP-1 Medications Affect Sleep Quality
Protection cardiovasculaire avec les traitements GLP-1 En plus de la perte de poids et du contrle de la glycmie, les agonistes du GLP-1, tels que le smaglutide, ont montr des effets bnfiques dans la rduction du risque d'vnements cardiovasculaires majeurs , notamment chez les personnes obses sans diabte